One of the enzymes known to regulate the cell cycle has now been shown to play a key role in mitosis

Jun 20, 2012
Livers from Cdk1 knockout (KO) mice (bottom row) display fewer but larger cells compared to wild type (WT) mice (top row), both before and after partial hepatectomy (PH)

Cyclin-dependent kinase 1 (Cdk1) is a member of the Cdk family of enzymes which control the cell cycle. Philipp Kaldis at the A*STAR Institute of Molecular and Cell Biology and co-workers have now shown that Cdk1 plays a critical role in cell division. Moreover, the researchers discovered that by inactivating Cdk production, they could prevent tumor formation in mice. The new finding may open up new avenues in the development of cancer drugs and treatment.

In the , there exist more than 20 different Cdks that regulate different phases of the cycle of cell division, or mitosis. Previous studies have shown that mice with any one of these genes knocked out remain viable, suggesting that enzymes of the Cdk1 family have overlapping roles. Due to technical difficulties, however, no for Cdk1 have so far been developed. Now, Kaldis and co-workers have not only generated Cdk1-knockout mice, but also developed adult mice in which active Cdk1 genes could be switched off by chemical means.

The researchers found in their experiment that mice lacking functional Cdk1 genes die within three and a half days of conception. Their also display fewer but larger cells. The researchers suggest the cells in very-early-stage embryos contain remnants of the products of the mother’s Cdk1 genes, which allows them to carry out limited cell division. Without Cdk1, the cells cannot divide and will instead continue to grow, suggesting that Cdk1 is critical to mitosis.

The researchers studied the role of Cdk1 in liver regeneration in adult mice. They found that of all the organs in the mammalian body, the liver could tolerate the loss of Cdk1 the most as its cells only divide in adulthood during regeneration. They made use of experimental animals whose livers were deficient in Cdk1. When they surgically removed part of the livers, the researchers found that regeneration still took place, not by producing more cells, but by increasing the size of existing cells.

The researchers also studied the impact of loss of Cdk1 activity on the generation of tumors, both in cell culture and in the livers of injected with carcinogens. They discovered that without Cdk1, tumor cells could not proliferate.

“We are now able to delete Cdk1 in any tissue or tumor type we choose at any time point,” says Kaldis. “So our mouse model offers a neat method to test whether drugs targeting Cdk1 activity can be effective in treating cancers.”

Explore further: Sugar mimics guide stem cells toward neural fate

More information: Diril, M. K. et al. Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration. Proceedings of the National Academy Sciences 109, 3826–3831 (2012).

add to favorites email to friend print save as pdf

Related Stories

Study supports DNA repair-blocker research in cancer therapy

Aug 17, 2009

Scientists at Dana-Farber Cancer Institute have uncovered the mechanism behind a promising new approach to cancer treatment: damaging cancer cells' DNA with potent drugs while simultaneously preventing the cells from repairing ...

Protein wields phosphate group to inhibit cancer metastasis

Jan 03, 2011

By sticking a chemical group to it at a specific site, a protein arrests an enzyme that may worsen and spread cancer, an international research team led by scientists at The University of Texas MD Anderson Cancer Center reports ...

Recommended for you

Sugar mimics guide stem cells toward neural fate

15 hours ago

Embryonic stem cells can develop into a multitude of cells types. Researchers would like to understand how to channel that development into the specific types of mature cells that make up the organs and other structures of ...

Researchers uncover secrets of internal cell fine-tuning

Jul 29, 2014

New research from scientists at the University of Kent has shown for the first time how the structures inside cells are regulated – a breakthrough that could have a major impact on cancer therapy development.

User comments : 0